164 related articles for article (PubMed ID: 16680591)
21. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
22. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
23. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors.
Sugitani I; Fujimoto Y
Endocr J; 1999 Feb; 46(1):209-16. PubMed ID: 10426589
[TBL] [Abstract][Full Text] [Related]
24. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
25. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
[TBL] [Abstract][Full Text] [Related]
26. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
27. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
28. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.
Ito Y; Hirokawa M; Jikuzono T; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2007 Jun; 31(6):1194-201. PubMed ID: 17431714
[TBL] [Abstract][Full Text] [Related]
29. A review of 227 cases of small papillary thyroid carcinoma.
Zuo H; Tang W; Yasuoka H; Nakamura Y; Ito Y; Miyauchi A; Kakudo K
Eur J Surg Oncol; 2007 Apr; 33(3):370-5. PubMed ID: 17071044
[TBL] [Abstract][Full Text] [Related]
30. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
31. Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up.
Neuhold N; Schultheis A; Hermann M; Krotla G; Koperek O; Birner P
Ann Surg Oncol; 2011 Nov; 18(12):3430-6. PubMed ID: 21431405
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
33. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
Verburg FA; Mäder U; Luster M; Reiners C
Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
[TBL] [Abstract][Full Text] [Related]
34. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
35. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
[TBL] [Abstract][Full Text] [Related]
36. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
37. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
38. Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma.
Buffet C; Golmard JL; Hoang C; Trésallet C; Du Pasquier Fédiaevsky L; Fierrard H; Aurengo A; Menegaux F; Leenhardt L
Eur J Endocrinol; 2012 Aug; 167(2):267-75. PubMed ID: 22648965
[TBL] [Abstract][Full Text] [Related]
39. Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
Cupisti K; Lehwald N; Anlauf M; Riemer J; Werner TA; Krieg A; Witte J; Chanab A; Baldus SE; Krausch M; Raffel A; Herdter C; Schott M; Knoefel WT
Horm Metab Res; 2014 Feb; 46(2):138-44. PubMed ID: 24356791
[TBL] [Abstract][Full Text] [Related]
40. Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients.
Gschwandtner E; Klatte T; Swietek N; Bures C; Kober F; Ott J; Schultheis A; Neuhold N; Hermann M
Surgery; 2016 Feb; 159(2):503-11. PubMed ID: 26189948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
